Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2011 by University of Vermont.
Recruitment status was:  Recruiting
Information provided by:
University of Vermont Identifier:
First received: June 21, 2010
Last updated: April 21, 2011
Last verified: April 2011
Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.


Study Type: Observational
Official Title: Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Further study details as provided by University of Vermont:

Biospecimen Retention:   Samples Without DNA
plasma, serum and platelet activated blood samples

Estimated Enrollment: 30
Study Start Date: June 2010
Estimated Study Completion Date: August 2013
Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with a malignancy diagnosis.

Inclusion Criteria:

  • Patients with a diagnosis of malignancy

Exclusion Criteria:

  • Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01148407

Contact: Chris E Holmes, MD, PhD 802-656-0302

United States, Vermont
University of Vermont/Fletcher Allen Health Care Recruiting
Burlington, Vermont, United States, 05401
Contact: Barbara Kelly   
Principal Investigator: Chris E Holmes, MD PhD         
Sponsors and Collaborators
University of Vermont
Principal Investigator: Chris E Holmes, MD PhD University of Vermont
  More Information

Responsible Party: Chris E. Holmes, MD, PhD, University of Vermont Identifier: NCT01148407     History of Changes
Other Study ID Numbers: VCC 0806
Study First Received: June 21, 2010
Last Updated: April 21, 2011

Keywords provided by University of Vermont:
breast cancer
metastatic cancer
malignancy processed this record on May 25, 2017